No differential DNA methylation of PARK2 in brain of Parkinson's disease patients and healthy controls

Movement Disorders

Volumn 28, Issue 14, 2013, Pages 2032-2033

  De Mena, Lorena ^a   Cardo, Lucía F ^a   Coto, Eliecer ^a,b   Alvarez, Victoria ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b UNIVERSITY OF OVIEDO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE; GENOMIC DNA; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; PARKIN; PARKIN 2; UNCLASSIFIED DRUG;

AUTOSOMAL RECESSIVE INHERITANCE; BRAIN REGION; BRAIN TISSUE; CHRONIC MYELOID LEUKEMIA; CLONE; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; GENE MUTATION; HUMAN; LETTER; LEUKOCYTE; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION SITE;

AGED; AGED, 80 AND OVER; BRAIN; DNA METHYLATION; FEMALE; HUMANS; MALE; PARKINSON DISEASE; UBIQUITIN-PROTEIN LIGASES;

EID: 84889685681     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25593     Document Type: Letter

References (6)

1. Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998;392:605-608.
2. Agirre X, Roman-Gomez J, Vazquez I, et al. Abnormal methylation of the common PARK2 and PACRG promoter is associated with down-regulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia. Int J Cancer 2009 6;118:1945-1953.
3. Jowaed A, Schmitt I, Kaut O, Wullner U. Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients' brains. J Neurosci 2020;30:6355-6359.
4. Matsumoto L, Takuma H, Tamaoka A, et al. CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson's disease [serial online]. PLoS One 2020;5:e15522.
5. Kaut O, Schmitt I, Wullner U. Genome-scale methylation analysis of Parkinson's disease patients' brains reveals DNA hypomethylation and increased mRNA expression of cytochrome P450 2E1. Neurogenetics 2012;13:87-91.
6. Cai M, Tian J, Zhao GH, Luo W, Zhang BR. Study of methylation levels of parkin gene promoter in Parkinson's disease patients. Int J Neurosci 2011;121:497-502.